TY - JOUR
T1 - Incidence of soft tissue sarcoma in Taiwan
T2 - A nationwide population-based study (2007–2013)
AU - Hung, Giun Yi
AU - Horng, Jiun Lin
AU - Chen, Paul Chih Hsueh
AU - Lin, Li Yih
AU - Chen, Jinn Yang
AU - Chuang, Pei Hung
AU - Chao, Ta Chung
AU - Yen, Chueh Chuan
N1 - Funding Information:
The data for STS registered in the nationwide TCR database during 2007–2013 were acquired from the Health and Welfare Data Science Center (HWDC), Ministry of Health and Welfare, Taiwan. The TCR is organized and funded by the Ministry of Health and Welfare, Taiwan, and has been collecting cancer data since 1979. Beginning with 2002 incidence data, the ICD-O-3 replaced the ICD-O, Field Trial Edition, for coding in the TCR. In 2003, the Cancer Control Act was enacted; it mandates that all hospitals with >50 beds, which provide outpatient and hospitalized cancer care, must submit cancer data to the central registry. The completeness and data quality of TCR database has been excellent since then. For the latest data (2015), the completeness of the TCR database was 98.17% [ 9 ]. Regarding the indices of data quality defined by the International Agency for Research on Cancer (IARC), an increased percentage of microscopy-verified registration (MV%) and decreased percentage of death certificate only (DCO%) have already been demonstrated [ 20 , 21 ]. STS diagnoses were made by specialist pathologists with board certification. For regional and district general hospitals without pathologists specializing in STS classification, the diagnoses were made by consulting the STS Committee of the Taiwan Society of Pathology, Taiwan Division of the International Academy of Pathology. TCR is one of the population-based cancer registries worldwide, with 100% coverage, and has been used in large-scale international studies for global surveillance of trends in cancer incidence and survival [ 22 ].
Funding Information:
This work was jointly supported by grants from the Ministry of Science and Technology, Taiwan ( MOST 103-2314-B-075-066 , MOST 105-2314-B-075-059 and MOST 106-2314-B-075-065 ), and Taipei Veterans General Hospital ( V103C-188 , V104C-099 , V104E16-001-MY3-1 , V104E16-001-MY3-2 , V104D16-001-MY3-3 , V105C-094 , V106C-160 , V107C-085 ) designated to Dr. Chueh-Chuan Yen, and from the Yen Tjing Ling Medical Foundation designated to Dr. Chueh-Chuan Yen (grant number CI-100-19 , CI-103-6, CI-105-4 ) and Dr. Giun-Yi Hung (grant number CI-107-12 ). This work was also supported by the Taiwan Clinical Oncology Research Foundation , and the Chong Hin Loon Memorial Cancer and Biotherapy Research Center of National Yang-Ming University, Taiwan . The funding source had no role in study design, collection, analysis and interpretation of data, or writing of this manuscript.
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/6
Y1 - 2019/6
N2 - Background: Asian studies on soft tissue sarcoma (STS) incidence, irrespective of the primary site, are scant. Methods: STS data were acquired from the population-based 2007–2013 Taiwan Cancer Registry of the Health and Welfare Data Science Center, Taiwan. Histological subtype-, site-, sex-, and age-specific STS incidence rates were analyzed according to the 2013 classification of the World Health Organization. Results: In total, 11,393 patients with an age-standardized incidence rate (ASIR) of 5.62 (95% confidence interval, 5.51–5.73) per 100,000 person-years were identified. Overall, a male predominance (sex-standardized incidence rate ratio, 1.2) was noted, and the rate increased with age, peaking at >75 years. Approximately 30% of STSs occurred in connective, subcutaneous, and other soft tissues and 70% in other sites. In addition to connective, subcutaneous, and other soft tissues, the three most common primary sites were the stomach (15.9%), skin (14.3%), and small intestines (10.5%). Gastrointestinal stromal tumor was the most common subtype (29.2%; ASIR, 1.55/100,000 person-years), followed by liposarcoma (11.5%; ASIR, 0.63/100,000 person-years) and leiomyosarcoma (9.7%; ASIR, 0.53/100,000 person-years). Compared with relevant data from Western countries, the incidence rate of angiosarcomas was higher than that in other regions, whereas the incidence rates of leiomyosarcoma and Kaposi sarcoma were lower than those in other regions. Conclusion: STS incidence varied by histological subtype, sex, age, and primary site in an Asian population. Our results suggested regional and racial discrepancies in the incidence rates of certain STS subtypes.
AB - Background: Asian studies on soft tissue sarcoma (STS) incidence, irrespective of the primary site, are scant. Methods: STS data were acquired from the population-based 2007–2013 Taiwan Cancer Registry of the Health and Welfare Data Science Center, Taiwan. Histological subtype-, site-, sex-, and age-specific STS incidence rates were analyzed according to the 2013 classification of the World Health Organization. Results: In total, 11,393 patients with an age-standardized incidence rate (ASIR) of 5.62 (95% confidence interval, 5.51–5.73) per 100,000 person-years were identified. Overall, a male predominance (sex-standardized incidence rate ratio, 1.2) was noted, and the rate increased with age, peaking at >75 years. Approximately 30% of STSs occurred in connective, subcutaneous, and other soft tissues and 70% in other sites. In addition to connective, subcutaneous, and other soft tissues, the three most common primary sites were the stomach (15.9%), skin (14.3%), and small intestines (10.5%). Gastrointestinal stromal tumor was the most common subtype (29.2%; ASIR, 1.55/100,000 person-years), followed by liposarcoma (11.5%; ASIR, 0.63/100,000 person-years) and leiomyosarcoma (9.7%; ASIR, 0.53/100,000 person-years). Compared with relevant data from Western countries, the incidence rate of angiosarcomas was higher than that in other regions, whereas the incidence rates of leiomyosarcoma and Kaposi sarcoma were lower than those in other regions. Conclusion: STS incidence varied by histological subtype, sex, age, and primary site in an Asian population. Our results suggested regional and racial discrepancies in the incidence rates of certain STS subtypes.
KW - Incidence
KW - Population-based
KW - Sarcoma
KW - Soft tissue
KW - Taiwan
UR - http://www.scopus.com/inward/record.url?scp=85064925385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064925385&partnerID=8YFLogxK
U2 - 10.1016/j.canep.2019.04.007
DO - 10.1016/j.canep.2019.04.007
M3 - Article
C2 - 31055220
AN - SCOPUS:85064925385
SN - 1877-7821
VL - 60
SP - 185
EP - 192
JO - Cancer Epidemiology
JF - Cancer Epidemiology
ER -